# Acute Migraine Treatment in the ED With Gepants

> **NCT06985342** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 9 (actual)

## Conditions studied

- Migraine Headaches

## Interventions

- **DRUG:** Rimegepant
- **DRUG:** Zavegepant

## Key facts

- **NCT ID:** NCT06985342
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-06-05
- **Primary completion:** 2026-01-06
- **Final completion:** 2026-02-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Study closing at current site. Study to start as new at different site.
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06985342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06985342, "Acute Migraine Treatment in the ED With Gepants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06985342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*